Amundi
RGNX icon

Amundi’s Regenxbio RGNX Stock Holding History

Amundi’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,988
Closed -$76.4K – 2188
2024
Q3 		$76.4K Hold
7,988
– – ﹤0.01% 1803
2024
Q2 		$86.4K Buy
7,988
+805
+11% +$12.5K ﹤0.01% 1721
2024
Q1 		$116K Buy
7,183
+1,754
+32% +$31.2K ﹤0.01% 1744
2023
Q4 		$79.6K Buy
5,429
+493
+10% +$8.68K ﹤0.01% 1819
2023
Q3 		$79.4K Hold
4,936
– – ﹤0.01% 1796
2023
Q2 		$98.7K Sell
4,936
-190
-4% -$3.66K ﹤0.01% 1774
2023
Q1 		$93.1K Buy
+5,126
New +$113K ﹤0.01% 1755

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi's RGNX Position: Q4 2024 in Review

Amundi sold out of Regenxbio (RGNX) in Q4 2024, closing a stake of 7,988 shares — an estimated $76.4K sold.

Amundi first reported a position in RGNX in Q1 2023 and held it in 7 quarters. The position peaked at $116K in Q1 2024. 177 funds tracked by Wall St. Rank hold RGNX as of Q4 2024.

  • Amundi reported no remaining Regenxbio position as of Q4 2024 after selling out during the quarter.
  • Amundi sold 7,988 Regenxbio shares in Q4 2024, an estimated $76.4K.
  • Amundi first reported a position in Regenxbio in Q1 2023 and held it in 7 quarters.
  • Amundi's Regenxbio position peaked at $116K in Q1 2024.
  • 177 funds tracked by Wall St. Rank held Regenxbio as of Q4 2024.

Based on Amundi's 13F filing for Q4 2024, filed 7 Feb 2025.